Cargando…
A G542X cystic fibrosis mouse model for examining nonsense mutation directed therapies
Nonsense mutations are present in 10% of patients with CF, produce a premature termination codon in CFTR mRNA causing early termination of translation, and lead to lack of CFTR function. There are no currently available animal models which contain a nonsense mutation in the endogenous Cftr locus tha...
Autores principales: | McHugh, Daniel R., Steele, Miarasa S., Valerio, Dana M., Miron, Alexander, Mann, Rachel J., LePage, David F., Conlon, Ronald A., Cotton, Calvin U., Drumm, Mitchell L., Hodges, Craig A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010256/ https://www.ncbi.nlm.nih.gov/pubmed/29924856 http://dx.doi.org/10.1371/journal.pone.0199573 |
Ejemplares similares
-
Synergy between Readthrough and Nonsense Mediated Decay Inhibition in a Murine Model of Cystic Fibrosis Nonsense Mutations
por: McHugh, Daniel R., et al.
Publicado: (2020) -
A Novel G542X CFTR Rat Model of Cystic Fibrosis Is Sensitive to Nonsense Mediated Decay
por: Sharma, Jyoti, et al.
Publicado: (2020) -
Growth deficits in cystic fibrosis mice begin in utero prior to IGF-1 reduction
por: Darrah, Rebecca, et al.
Publicado: (2017) -
Delivering on the promise of gene editing for cystic fibrosis
por: Hodges, Craig A., et al.
Publicado: (2018) -
A BAC Transgene Expressing Human CFTR under Control of Its Regulatory Elements Rescues Cftr Knockout Mice
por: Gawenis, Lara R., et al.
Publicado: (2019)